Bird Flu Cases Among Dairy Workers Flew Under The Radar, Study Finds
November 8, 2024
Morning Briefing
As a result, the CDC recommends all workers on farms with infected animals be tested and offered treatment.
ACA, Abortion Rights Among Health Care Priorities Of New Senate Dems
November 8, 2024
Morning Briefing
Roll Call lays out what newly elected members have championed in the past and what perspective they might bring to the GOP-controlled Senate. Meanwhile, one more government spending battle looms in Congress.
DCF Mismanaged Health Care Of Kids, Massachusetts’ State Audit Finds
November 8, 2024
Morning Briefing
Thirty-five percent of cases reviewed show signs of lack of care for kids with serious mental health conditions, including missed therapy sessions, missing information on file, and, in some cases, improperly prescribed antipsychotics. Almost a quarter of all kids in protective custody had a prescription for at least one psychotropic medication.
FDA Aims To Yank From The Market A Common But Ineffective Decongestant
November 8, 2024
Morning Briefing
The ingredient, called oral phenylephrine, is commonly used in cough and cold medicines. Also: Monkeys are on the loose from a South Carolina research facility; a North Carolina hospital files for bankruptcy; a Maine hospital ends labor and delivery services; a historic fetal surgery at Children’s Hospital of Philadelphia; and more.
Morning Briefing for Friday, November 8, 2024
November 8, 2024
Morning Briefing
The KFF Health News Morning Briefing will not be published Monday in observance of Veterans Day. Look for it again in your inbox on Tuesday.
Trump’s Campaign Guru, A Tobacco Lobbyist, Will Be His Chief Of Staff
November 8, 2024
Morning Briefing
Susie Wiles, who also helped Florida Gov. Ron DeSantis to victory in 2018, will be the first woman in the role. Wiles also worked as a tobacco lobbyist for Swisher International during the 2024 campaign, and her firm, Mercury Public Affairs, also has “large lobbying contracts with several junk food companies,” the investigative outlet Sludge reported.
4 Million Americans Could Lose Health Insurance In 2026 Under GOP, Trump
November 8, 2024
Morning Briefing
The Congressional Budget Office estimates that if subsidies are allowed to expire next year, nearly 4 million people will lose their coverage in 2026 because they won’t be able to afford it, NBC News reports. In other policy news: vaccines’ future; fluoride in the water; and more.
First Edition: Friday, Nov. 8, 2024
November 8, 2024
Morning Briefing
Today’s early morning highlights from the major news organizations. Note to readers: The First Edition will not be published Monday in observance of Veterans Day. Look for it again in your inbox on Tuesday.
California Expanded Medi-Cal to Unauthorized Residents. The Results Are Mixed.
By Vanessa G. Sánchez
November 8, 2024
KFF Health News Original
California this year completed its Medi-Cal expansion to include income-eligible residents regardless of their immigration status. This final installment of the “Faces of Medi-Cal” series profiles three of those newly eligible patients and how coverage has affected their health.
Watchdog Calls for Tighter Scrutiny of Medicare Advantage Home Visits
By Fred Schulte
November 8, 2024
KFF Health News Original
Medicare officials defend the use of home visits that often spot medical conditions that are never treated.
7 of 10 States Backed Abortion Rights, but Don’t Expect Change Overnight
By Bram Sable-Smith
November 7, 2024
KFF Health News Original
Voters backed abortion rights in seven of the 10 states where the issue appeared on ballots Tuesday, including in Missouri, among the first states to ban abortion after the U.S. Supreme Court overturned federal abortion protections with its 2022 decision in Dobbs v. Jackson Women’s Health Organization. At first glance, the nation’s patchwork of abortion […]
Patchwork Of State Abortion Laws Gets Even More Complex After Elections
November 7, 2024
Morning Briefing
Despite historic results in Tuesday’s elections, abortion-rights advocates are warning that opportunities for more ballot measures might be dwindling.
Ban Overturned, Missouri’s Abortion Fight Enters Tricky Legal Territory
November 7, 2024
Morning Briefing
Residents voted to undo the state’s strict abortion ban, but they also voted to stack the state government with Republicans who oppose abortion. Meanwhile, Planned Parenthood workers on Wednesday filed paperwork to begin the process of invalidating the state’s ban.
LGBTQ+ Crisis Hotlines See Huge Increase In Calls, Texts
November 7, 2024
Morning Briefing
All across the country, LGBTQ+ hotlines, focused on the mental health and well-being of the community, have received an extraordinary influx of calls and texts in the days leading up to and since the election.
Depression And Anxiety Increased By Over 2.5% Post Pandemic, Study Finds
November 7, 2024
Morning Briefing
The number of American adults experiencing depression went up by 2.9%, while those experiencing anxiety increased by 2.6% in relation to data from 2019. Other news includes teen caffeine overdoses, cheese recalls, and more.
Nebraska Allows Medical Marijuana; Colorado Springs Likely To Ban Recreational Pot
November 7, 2024
Morning Briefing
After voters rejected ballot measures in three states, recreational cannabis advocates are shifting their focus to state legislatures and the federal government. Also, Jelly Roll weighs in on how a little weed keeps him sober.
4 Cases Of New Mpox Variant ID’d In The UK, A First Outside Of Africa
November 7, 2024
Morning Briefing
AP reports on the new U.K. cluster, noting that scientists say public risk remains low. Other global health news is on cigarettes in the U.K., a social media ban in Australia, the future of cancer disparities, and more.
Novo Nordisk CEO Flags 10 Deaths That Might Be Related To Compounded Semaglutide
November 7, 2024
Morning Briefing
The pharmaceutical company says data on 10 deaths and more than 100 hospitalizations comes from the FDA’s adverse event reporting database for semaglutide — the key ingredient in Ozempic and Wegovy, which are manufactured by Novo Nordisk. Compounded versions of the drug are made by other companies in times of shortages. FDA adverse event reports aren’t verified and don’t mean the drugs have caused the harms documented.
Morning Briefing for Thursday, November 7, 2024
November 7, 2024
Morning Briefing
Who will Trump pick to lead health agencies? Plus, abortion ballot measures, opioid settlement funds, syphilis, weight loss drugs, and more
